This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Side-effects

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Side-effects with tamoxifen are unusual.

Unwanted effects include:

  • vaginal bleeding
  • hot flushes - treatment with clonidine has been shown to be effective in reducing tamoxifen associated hot flushes in postmenopausal women with breast cancer (2)
  • suppression of menstruation
  • gastrointestinal disturbance
  • increased bone pain from metastases
  • rarely, hypercalcaemia in metastatic disease
  • thromboembolism

The incidence of symptomatic endometrial cancer in patients taking tamoxifen is estimated to be less than 20 in 10000 women treated per year.

Reference:

  • (1) Bergman, E, Beelen, MLR. et al. (2000). Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet, 356, 881-7.
  • (2) Pandya KJ et al (2000). Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flushes: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Ann Intern Med, 132, 788-93.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.